136 related articles for article (PubMed ID: 38607297)
21. Deconstructing Sonic Hedgehog Medulloblastoma: Molecular Subtypes, Drivers, and Beyond.
Garcia-Lopez J; Kumar R; Smith KS; Northcott PA
Trends Genet; 2021 Mar; 37(3):235-250. PubMed ID: 33272592
[TBL] [Abstract][Full Text] [Related]
22. Molecular profile reveals immune-associated markers of medulloblastoma for different subtypes.
Chen J; Kang Z; Li S; Wang C; Zheng X; Cai Z; Pan L; Chen F; Li W
Front Immunol; 2022; 13():911260. PubMed ID: 35967388
[TBL] [Abstract][Full Text] [Related]
23. Advanced MRI Findings in Medulloblastomas: Relationship to Genetic Subtypes, Histopathology, and Immunohistochemistry.
Reis J; Stahl R; Zimmermann H; Ruf V; Thon N; Kunz M; Liebig T; Forbrig R
J Neuroimaging; 2021 Mar; 31(2):306-316. PubMed ID: 33465267
[TBL] [Abstract][Full Text] [Related]
24. BarTeL, a Genetically Versatile, Bioluminescent and Granule Neuron Precursor-Targeted Mouse Model for Medulloblastoma.
Shackleford GM; Shi XH; Swanson KS; Mahdi MY; Gonzalez-Gomez I; Asgharzadeh S; D'Apuzzo M; Erdreich-Epstein A; Moats RA
PLoS One; 2016; 11(6):e0156907. PubMed ID: 27310018
[TBL] [Abstract][Full Text] [Related]
25. Stem-Like Cell Populations, p53-Pathway Activation and Mechanisms of Recurrence in Sonic Hedgehog Medulloblastoma.
Treisman D; Li Y; Zhu Y
Neuromolecular Med; 2022 Mar; 24(1):13-17. PubMed ID: 34165693
[TBL] [Abstract][Full Text] [Related]
26. Targeting sonic hedgehog-associated medulloblastoma through inhibition of Aurora and Polo-like kinases.
Markant SL; Esparza LA; Sun J; Barton KL; McCoig LM; Grant GA; Crawford JR; Levy ML; Northcott PA; Shih D; Remke M; Taylor MD; Wechsler-Reya RJ
Cancer Res; 2013 Oct; 73(20):6310-22. PubMed ID: 24067506
[TBL] [Abstract][Full Text] [Related]
27. Functional loss of a noncanonical BCOR-PRC1.1 complex accelerates SHH-driven medulloblastoma formation.
Kutscher LM; Okonechnikov K; Batora NV; Clark J; Silva PBG; Vouri M; van Rijn S; Sieber L; Statz B; Gearhart MD; Shiraishi R; Mack N; Orr BA; Korshunov A; Gudenas BL; Smith KS; Mercier AL; Ayrault O; Hoshino M; Kool M; von Hoff K; Graf N; Fleischhack G; Bardwell VJ; Pfister SM; Northcott PA; Kawauchi D
Genes Dev; 2020 Sep; 34(17-18):1161-1176. PubMed ID: 32820036
[TBL] [Abstract][Full Text] [Related]
28. Immunohistochemical Surrogates for Molecular Stratification in Medulloblastoma.
Chinnam D; Saraswati A; Jogunoori S; Verma A; Kiran T; Salunke P; Gupta N; Kumar N; Madan R; Radotra BD; Gupta K
Appl Immunohistochem Mol Morphol; 2023 Sep; 31(8):561-568. PubMed ID: 37471625
[TBL] [Abstract][Full Text] [Related]
29. Molecular Stratification of Medulloblastoma: Clinical Outcomes and Therapeutic Interventions.
Sursal T; Ronecker JS; Dicpinigaitis AJ; Mohan AL; Tobias ME; Gandhi CD; Jhanwar-Uniyal M
Anticancer Res; 2022 May; 42(5):2225-2239. PubMed ID: 35489737
[TBL] [Abstract][Full Text] [Related]
30. Exosomal microRNAs induce tumor-associated macrophages via PPARγ during tumor progression in SHH medulloblastoma.
Zhu L; Yang Y; Li H; Xu L; You H; Liu Y; Liu Z; Liu X; Zheng D; Bie J; Li J; Song C; Yang B; Luo J; Chang Q
Cancer Lett; 2022 Jun; 535():215630. PubMed ID: 35304257
[TBL] [Abstract][Full Text] [Related]
31. Immunohistochemical and nanoString-Based Subgrouping of Clinical Medulloblastoma Samples.
D'Arcy CE; Nobre LF; Arnaldo A; Ramaswamy V; Taylor MD; Naz-Hazrati L; Hawkins CE
J Neuropathol Exp Neurol; 2020 Apr; 79(4):437-447. PubMed ID: 32053195
[TBL] [Abstract][Full Text] [Related]
32. Principles of tumorigenesis and emerging molecular drivers of SHH-activated medulloblastomas.
Menyhárt O; Győrffy B
Ann Clin Transl Neurol; 2019 May; 6(5):990-1005. PubMed ID: 31139698
[TBL] [Abstract][Full Text] [Related]
33. A Benzarone Derivative Inhibits EYA to Suppress Tumor Growth in SHH Medulloblastoma.
Hwang GH; Pazyra-Murphy MF; Seo HS; Dhe-Paganon S; Stopka SA; DiPiazza M; Sutter N; Gero TW; Volkert A; Ombelets L; Dittemore G; Rees MG; Ronan MM; Roth JA; Agar NYR; Scott DA; Segal RA
Cancer Res; 2024 Mar; 84(6):872-886. PubMed ID: 38486486
[TBL] [Abstract][Full Text] [Related]
34. Sox2 requirement in sonic hedgehog-associated medulloblastoma.
Ahlfeld J; Favaro R; Pagella P; Kretzschmar HA; Nicolis S; Schüller U
Cancer Res; 2013 Jun; 73(12):3796-807. PubMed ID: 23596255
[TBL] [Abstract][Full Text] [Related]
35. Molecular therapy targeting Sonic hedgehog and hepatocyte growth factor signaling in a mouse model of medulloblastoma.
Coon V; Laukert T; Pedone CA; Laterra J; Kim KJ; Fults DW
Mol Cancer Ther; 2010 Sep; 9(9):2627-36. PubMed ID: 20807782
[TBL] [Abstract][Full Text] [Related]
36. Differential response of SHH-expressing adult medulloblastomas to the sonic hedgehog inhibitor vismodegib: whole-genome analysis.
Lou E; Nelson AC; Kool M
Cancer Biol Ther; 2019; 20(11):1398-1402. PubMed ID: 31423907
[TBL] [Abstract][Full Text] [Related]
37. Nomograms based on preoperative multiparametric magnetic resonance imaging for prediction of molecular subgrouping in medulloblastoma: results from a radiogenomics study of 111 patients.
Dasgupta A; Gupta T; Pungavkar S; Shirsat N; Epari S; Chinnaswamy G; Mahajan A; Janu A; Moiyadi A; Kannan S; Krishnatry R; Sastri GJ; Jalali R
Neuro Oncol; 2019 Jan; 21(1):115-124. PubMed ID: 29846693
[TBL] [Abstract][Full Text] [Related]
38. IGFBP2 promotes proliferation and cell migration through STAT3 signaling in Sonic hedgehog medulloblastoma.
Kunhiraman H; McSwain L; Shahab SW; Gershon TR; MacDonald TJ; Kenney AM
Acta Neuropathol Commun; 2023 Apr; 11(1):62. PubMed ID: 37029430
[TBL] [Abstract][Full Text] [Related]
39. Sonic hedgehog-associated medulloblastoma arising from the cochlear nuclei of the brainstem.
Grammel D; Warmuth-Metz M; von Bueren AO; Kool M; Pietsch T; Kretzschmar HA; Rowitch DH; Rutkowski S; Pfister SM; Schüller U
Acta Neuropathol; 2012 Apr; 123(4):601-14. PubMed ID: 22349907
[TBL] [Abstract][Full Text] [Related]
40. Low Expression of the
de Araújo MA; Malafaia O; Ribas Filho JM; Fratini L; Roesler R; Isolan GR
Int J Mol Sci; 2023 Jul; 24(14):. PubMed ID: 37511358
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
